| Lindsay Allan Rosenwald |
Lindsay Allan Rosenwald was the founder of TG Therapeutics, Inc. (founded in 2012), Paramount BioCapital Asset Management, Inc. (founded in 1991), Keryx Biopharmaceuticals, Inc. (founded in 1994), Cougar Biotechnology, Inc. (founded in 2003), Paramount BioSciences LLC (founded in 1991), Opus Point Partners Management LLC (founded in 2009), Helocyte, Inc. (founded in 2015), and Cyprium Therapeutics, Inc. (founded in 2017). Dr. Rosenwald's current job(s) included being the Executive Chairman, President & CEO at Fortress Biotech, Inc. (since 2009), Executive Chairman at Cellvation, Inc., Executive Chairman at Journey Medical Corp. (since 2014), Non-Executive Director at Checkpoint Therapeutics, Inc. (since 2014), Director at Avenue Therapeutics, Inc. (since 2015), Non-Executive Director at Mustang Bio, Inc. (since 2015), Director at Caelum Biosciences, Inc., and Director at Baergic Bio, Inc.Dr. Rosenwald's former job(s) included being the Chairman & Chief Executive Officer at Paramount BioCapital Asset Management, Inc. (1991-2010), Director at Keryx Biopharmaceuticals, Inc. (2000-2006), Director at Cougar Biotechnology, Inc. (2003-2007), Chairman & Chief Executive Officer at Paramount BioSciences LLC (2011), Partner at Opus Point Partners Management LLC, Chairman & Chief Executive Officer at Paramount BioCapital, Inc. (1991-2008), Co-Chairman & Chief Executive Officer at Origo Acquisition Corp. (2014-2016), and Securities Analyst at Ladenburg Thalmann & Co., Inc.Dr. Rosenwald's education history included an undergraduate degree from The Pennsylvania State University and a doctorate degree from Temple University School of Medicine (conferred in 1983). |
| J. Jay Lobell |
J. Jay Lobell is the founder of Capital One Multifamily Finance LLC (founded in 2009), GMF Capital LLC (founded in 2016), GMF Real Estate LLC (founded in 2015), and Jsb Capital Group LLC (founded in 2021). Mr. Lobell's current jobs include Director at Tikvah Therapeutics, Inc., Independent Director at Fortress Biotech, Inc. (since 2006), Director at SavaSeniorCare LLC (since 2013), and Director at Tender Touch Rehabilitation Services (since 2014). Mr. Lobell's former jobs include Chief Executive Officer & Secretary at Paramount Acquisition Corp., Director at TG Therapeutics, Inc., Director at NovaDel Pharma, Inc., Director at Innovive Pharmaceuticals, Inc. (from 2006 to 2008), Director at TRACON Pharmaceuticals, Inc., Independent Director at IASO Pharma, Inc. (in 2012), President & Director at Meridian Capital Group LLC (from 2008 to 2015), Director at B.J.K., Inc., Director at CRC Parent Corp. (from 2005 to 2010), Independent Director at Pardes Biosciences, Inc. (from 2021 to 2023), President at Paramount BioCapital Asset Management, Inc., President & Chief Operating Officer at Paramount BioCapital, Inc. (from 2005 to 2009), President & Secretary at Sitka Sciences, Inc., and Partner at Covington & Burling LLP (from 1996 to 2005). Mr. Lobell's education includes an undergraduate degree from City University of New York and a graduate degree from Yale Law School (conferred in 1988). |
| Jimmie Harvey |
Jimmie Harvey is the founder of Birmingham Hematology & Oncology Associates LLC, which was founded in 1984. He is currently an Independent Director at Fortress Biotech, Inc. since 2008. Dr. Harvey received his undergraduate degree from Emory University and his doctorate from Emory University School of Medicine. |
| Malcolm I. Hoenlein |
Malcolm I. Hoenlein is currently the Executive Vice Chairman of the Conference of Presidents of Major Amer. Jewish Organizations since 2019. He is also an Independent Director at Fortress Biotech, Inc. since 2014 and an Independent Director at Schottenstein Realty Trust, Inc. since 2011. Additionally, he serves as a Director at Nanox Imaging Plc, ODF Optronics Ltd., Eco Fusion Ltd., Nuvo Corp., and MayMaan Research, Inc. In his former positions, Dr. Hoenlein served as a Director at TG Therapeutics, Inc. from 2004 to 2010. He was also an Independent Director at PureSafe Water Systems, Inc. from 2008 to 2012. Furthermore, he held directorial roles at Piksel, Inc., Keryx Biopharmaceuticals, Inc., Bonus Biogroup Ltd., Wellsense Technologies LLC, DarioHealth Corp., Newmed Energy LP, Delek Energy Systems Ltd., Bank Leumi USA, Council on Foreign Relations, Inc., Jewish Community Relations Council of New York, Inc., National Conference on Soviet Jewry, Powermat USA LLC, Eco-Fusion North America, Inc., The Greater New York Conference On Soviet Jewry, and Foreign Policy Research Institute. Dr. Hoenlein obtained a graduate degree from the University of Pennsylvania, an undergraduate degree from Temple University (Pennsylvania), and a doctorate degree from Touro College. |
| Dov Klein |
Dov Klein is an Independent Director at Fortress Biotech, Inc. and a Member of The American Institute of Certified Public Accountants, Florida Institute of Certified Public Accountants, and New York State Society of Certified Public Accountants. He was previously an Audit Partner at Marks Paneth LLP and RSSM CPA LLP, and a Director at Laser Master International, Inc. He received his undergraduate degree from Brooklyn College in 1976. |
| Kevin L. Lorenz |
Kevin L. Lorenz is an Independent Director at Fortress Biotech, Inc. and the Chief Investment Officer & SVP-Treasury at Katz Group, Inc. He previously worked as a Director-UHNW Management Group at UBS Financial Services, Inc. from 2004 to 2009. He also held Director positions at PharmaJet, Inc., Credit Suisse Securities (Canada), Inc., and Credit Suisse Securities (Moscow) CJSC. Lorenz holds an MBA from Benedictine University, an undergraduate degree from Illinois State University, and a graduate degree from George Mason University School of Law. |
